Results of a new study challenge the current consensus in cardiology that peak myocardial edema, or heart muscle swelling, only occurs just after a myocardial infarction, or heart attack.
Brief usage of the painkiller oxycodone may impair behavioral flexibility even after that use ends, suggesting impaired decision-making as an enduring consequence of exposure, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published November 17 in the journal Learning and Memory.
Fatigue, increased irritability, and feeling demoralized, may raise a healthy man or woman’s risk of first-time cardiovascular disease by 36 percent, according to a study led by researchers at Mount Sinai St. Luke’s and Mount Sinai Roosevelt hospitals presented on Nov. 17 at the American Heart Association’s Scientific Sessions 2014 in Chicago, IL.
Researchers from the Icahn School of Medicine at Mount Sinai are seeking patients with mild-to-moderate Alzheimer’s disease (AD) to take part in a study of an investigational agent which may have the potential to protect nerve cells in the brain.
Discovery of new molecular and behavioural connections may provide a foundation for the development of new treatments to combat some forms of depression
The Icahn School of Medicine at Mount Sinai’s Institute for Personalized Medicine is launching a study designed to learn whether patients, who are aware of their genetic predisposition to chronic kidney disease, are more inclined to engage in proactive lifestyle modification with their primary care physician.
The Centers for Medicare and Medicaid Services (CMS) today recognized the importance of lung cancer screening, announcing today that it will cover low-dose computed tomography (CT) screening, or “CAT” scans , for high-risk current and former smokers. The decision validates Mount Sinai’s longstanding commitment to providing access to this essential screening tool.
New DNA regulatory technique modifies the environment around a single gene to control gene expression and behavioral consequences
Lung cancer accounts for more annual deaths than colon, breast, and prostate cancers combined. It is the number one cancer killer of women. The American Cancer Society estimates that in 2014, approximately 224,110 new cases of lung cancer will be diagnosed in the United States, and over 155,000 will die from this disease. Mount Sinai research has shown that early CT screening for leads to early diagnosis and treatment which saves lives. Men and women with an increased risk of lung cancer – ages 55 or older, former and current smokers – should get screened annually. November is lung cancer awareness month, and the following experts are available to report on emerging trends in the field.
The Mount Sinai Health System today announced the appointment of Sandra Myerson, MBA, MS, BSN, RN, to the newly-created position of Senior Vice President and Chief Patient Experience Officer of the Mount Sinai Health System and of the Joseph F. Cullman Jr. Institute for Patient Care.
Charles Shapiro, MD, joins Mount Sinai as the Co-Director of the Dubin Breast Center, Director of Translational Breast Cancer Research for the Mount Sinai Health System, and Director of Survivorship Programs at The Tisch Cancer Institute at Mount Sinai
Newfound Genetic Differences Provide Many Hints at Causes
New York Eye and Ear Infirmary of Mount Sinai announced today it has received national recognition for excellence in nursing for the second consecutive time from the American Nurses Credentialing Center’s (ANCC) Magnet Recognition Program®.
Diabetes is the seventh leading cause of death in the United States. Today, 29.1 million people in the United States have been diagnosed with diabetes, according to the Centers for Disease Control and Prevention (CDC). November is Diabetes Awareness month and Mount Sinai experts are sharing tips on prevention and detection.
Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists from Icahn School of Medicine at Mount Sinai and published in the October issue of JACC Cardiovascular Imaging.
Preexisting differences in the sensitivity of a key part of each individual’s immune system to stress confer a greater risk of developing stress-related depression or anxiety
On Saturday, October 18, 2014, the Ear Institute at the New York Eye and Ear Infirmary of Mount Sinai (NYEE) will host an unveiling event by the Children’s Hearing Institute (CHI) and Marvel Custom Solutions to reveal the identity of a new girl super hero with cochlear implants.
A team led by researchers at The Rockefeller University and the Icahn School of Medicine at Mount Sinai has explained the function of key immune protein and solved an international medical mystery, according to a letter published this week in the journal Nature.
Rates of birth complications for mothers and newborns varied substantially between hospitals and were not correlated with performance measures designed to assess quality of obstetric care
10-institution study seeks to pilot new treatment approaches
The Mount Sinai Hospital is first in the United States to use the first and only FDA-approved, drug-coated balloon to open blocked arteries in the leg.
A Mount Sinai-led research team has discovered a new kind of stem cell that can become either a liver cell or a cell that lines liver blood vessels, according to a study published today in the journal Stem Cell Reports.
A Mount Sinai research team has received a $20 million grant from the National Institutes of Health (NIH) to create a center that will integrate databases and build computer models that glean new insights on how human cells react to drugs and toxins.
A key mechanism behind diabetes may start in the brain, with early signs of the disease detectable through rising levels of molecules not previously linked to insulin signaling, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai published today in the journal Cell Metabolism.
The Healthfirst Mount Sinai Select (HMO) plan is an alternative to the traditional Medicare program and allows Medicare beneficiaries to secure private insurance coverage financed by the federal government.
The Mount Sinai Health System will host five free Sudden Cardiac Arrest Awareness Fairs this October in honor of National Sudden Cardiac Arrest Awareness Month to increase the community’s knowledge about what sudden cardiac arrest (SCA) is and save more lives from it by teaching lifesaving hands-only CPR, and how to properly use an automated external defibrillator (AED).
Mount Sinai Heart has named its Cardiac Catheterization Laboratory the “Dr. Samin K. Sharma Family Foundation Cardiac Catheterization Laboratory,” in honor of Samin Sharma, MD, who serves as its Director of Clinical and Interventional Cardiology at The Mount Sinai Hospital.
Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders.
Ketan Badani, MD, Professor of Urology, Icahn School of Medicine at Mount Sinai, has been named Vice Chairman of Urology and Robotic Operations and Director of the Comprehensive Kidney Cancer Program for the Mount Sinai Health System.
Interventional Cardiologist William Gotsis, MD, has been appointed Director of Clinical Cardiology of Mount Sinai Heart at Mount Sinai St. Luke’s. Dr. Gotsis joins Mount Sinai St. Luke’s from Crystal Run Healthcare.
An experimental positron emission tomography (PET) tracer is effective in diagnosing concussion-related brain disease while a person is still alive, according to a case study conducted at the Icahn School of Medicine at Mount Sinai, and at Molecular Neuroimaging (MNI) LLC in New Haven, and published September 16 in the journal Translational Psychiatry.
Standard of care treatment for early-stage Hodgkin’s Disease has included combined therapy of chemotherapy followed by radiation therapy (RT), but use of RT has not been universal. The purpose of this large-scale study was to examine the association between RT use and overall survival over time in early-stage HD.
Researchers from Icahn School of Medicine at Mount Sinai have received a $1.1 million grant from the World Trade Center Health Program to study the risks of kidney and heart disease among Ground Zero first-responders and volunteers exposed to the toxic dust-cloud created by the disaster 13 years ago.
The center’s first mission will be to find FDA-approved drugs that reduce side effects when paired with hundreds of leading drugs against common, deadly diseases.
Gold standard for evaluating impact of chemicals on children’s health.
Exposure to violence has a different effect on people with aggressive traits
Holistic approach to disease prevention, treatment and detection
New research shows a novel polypill increases patient adherence to treatment following a myocardial infarction (MI) or heart attack, according to new study results reported at the European Society of Cardiology’s ESC Congress 2014 in Barcelona, Spain by Principal Investigator Valentin Fuster, MD, PhD.
Ovarian cancer is the fourth leading cause of death in American women, with about 22,000 diagnosed and 14,000 dying from the disease each year. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.
Experts from The Mount Sinai Hospital offer smart-eating strategies that will keep you healthy and fully satisfied while watching the matches.
Treatment with an inexpensive, decades-old clotting drug reduces the need for blood transfusions
A day spent outdoors watching tennis without proper protection can cause sunburn to both your skin and eyes.
Some ace tips for the audience.
$1.9 million in federal funding received through the Fund for Public Health and NYC DOHMH
The program tracks the status of implanted cardiac rhythm devices and provides secure data to hospitals, satellite practices, affiliates and Mount Sinai-owned practices through each patient’s electronic health record (EHR).
One of the human body’s first responses to a viral infection is to make and release signaling proteins called interferons, which amplify the immune system response to viruses. Over time, many viruses have evolved to undermine interferon’s immune-boosting signal, and a paper published today in the journal Cell Host & Microbe describes a mechanism unique to the Ebola virus that defeats attempts by interferon to block viral reproduction in infected cells.
Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD)
While in Germany, Partho P. Sengupta, MD, of Icahn School of Medicine at Mount Sinai used a computer to perform a robot-assisted trans-Atlantic ultrasound examination on a person in Boston. In another study Kurt Boman, MD, of Umeå University in Sweden in collaboration with Mount Sinai, showed how a cardiologist’s video e-consultation, coupled with a remote robot-assisted echocardiogram test, dramatically reduces the waiting time for a diagnosis faced by heart failure patients.
People who suffer from a rare illness, the Mal de Debarquement Syndrome (MdDS), now have a chance for full recovery thanks to treatment developed by researchers at the Icahn School of Medicine at Mount Sinai.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right